Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin
Event: ESC Congress 2021 - The Digital Experience
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session: Congress committee e-posters choice in heart failure
